Cargando…

Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer

BACKGROUND: Resection of liver metastases from colorectal cancer (CRC) in the oligometastatic stage improves survival and is a potentially curative treatment. Thus, predictive scores that reliably identify those patients who especially benefit from surgery are essential. PATIENTS AND METHODS: In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filippini Velázquez, G., Schiele, S., Gerken, M., Neumaier, S., Hackl, C., Mayr, P., Klinkhammer-Schalke, M., Illerhaus, G., Schlitt, H.J., Anthuber, M., Kröncke, T., Messmann, H., Märkl, B., Schmid, C., Trepel, M., Müller, G., Claus, R., Hackanson, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271475/ https://www.ncbi.nlm.nih.gov/pubmed/35461024 http://dx.doi.org/10.1016/j.esmoop.2022.100470

Ejemplares similares

Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma
por: Hackl, Christina, et al.
Publicado: (2014)

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis
por: Glockzin, Gabriel, et al.
Publicado: (2014)

Stricture Prevention after Extensive Endoscopic Submucosal Dissection of Neoplastic Barrett's Esophagus: Individualized Oral Steroid Prophylaxis
por: Probst, Andreas, et al.
Publicado: (2019)

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
por: Teufel, Andreas, et al.
Publicado: (2015)

Searching for novel multimodal treatments in oligometastatic pancreatic cancer
por: Filippini, D. M., et al.
Publicado: (2020)

Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection: a high-quality population-based analysis in a Southern German district
por: Draeger, Teresa, et al.
Publicado: (2018)

Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district
por: Völkel, Vinzenz, et al.
Publicado: (2018)

Endoscopic submucosal dissection for rectal neoplasia extending to the dentate line: European experience
por: Probst, Andreas, et al.
Publicado: (2018)

A new simple morphology‐based risk score is prognostic in stage I/II colon cancers
por: Märkl, Bruno, et al.
Publicado: (2016)

Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients
por: Taubenhansl, Clara, et al.
Publicado: (2019)

Characteristics and outcome of patients with small bowel adenocarcinoma (SBA)
por: Teufel, Andreas, et al.
Publicado: (2022)

Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in Germany
por: Völkel, Vinzenz, et al.
Publicado: (2021)

Chirurgische Therapie des Adenokarzinoms des ösophagogastralen Übergangs Typ II: Vergleich zwischen transhiatal erweiterter Gastrektomie und thorakoabdomineller Ösophagektomie
por: Stürzl, Roman, et al.
Publicado: (2022)

Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort
por: Schnitzbauer, Valentin, et al.
Publicado: (2019)

Auswirkungen der COVID-19-Pandemie auf die Inzidenz und Therapie von Krebserkrankungen
por: Inwald, Elisabeth C., et al.
Publicado: (2022)

Patients with Localised Prostate Cancer (T1 - T2) Show Improved Overall Long-Term Survival Compared to the Normal Population
por: Mathers, Michael J., et al.
Publicado: (2011)

Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany
por: Voelkel, Vinzenz, et al.
Publicado: (2019)

PB2126: R-CPOP AS FIRST LINE TREATMENT FOR DLBCL PATIENTS WITH SIGNIFICANT REDUCED LVEF OR HIGH RISK OF ANTHRACYCLINE INDUCED CARDIOTOXICITY
por: Lorenz, K., et al.
Publicado: (2022)

Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera
por: Papathemelis, Thomas, et al.
Publicado: (2018)

Guideline concordant therapy improves survival in high-grade endometrial cancer patients
por: Scharl, Sophia, et al.
Publicado: (2022)

Impact of cavity shaving on residual tumor rates in patients with primary invasive carcinoma and carcinoma in situ in breast conserving surgery
por: Fernández-Pacheco, Miriam, et al.
Publicado: (2022)

Tumor proportion in colon cancer: results from a semiautomatic image analysis approach
por: Martin, Benedikt, et al.
Publicado: (2020)

Correction to: Tumor proportion in colon cancer: results from a semiautomatic image analysis approach
por: Martin, Benedikt, et al.
Publicado: (2021)

The current role of precision surgery in oligometastatic prostate cancer
por: von Deimling, M., et al.
Publicado: (2022)

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects
por: Munker, Stefan, et al.
Publicado: (2018)

Endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: long-term follow-up in a Western center
por: Probst, Andreas, et al.
Publicado: (2023)

Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma—An Analysis of a Certified Tumor Registry over 17 Years
por: Prantl, Lukas, et al.
Publicado: (2020)

Intracranial Grade II Meningioma Oligometastatic to the Cervical Spine
por: Natarajan, Jyotsna M, et al.
Publicado: (2021)

Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients
por: Schmuck, Rosa, et al.
Publicado: (2020)

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma
por: Fante, Matthias A., et al.
Publicado: (2022)

Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology
por: Inwald, EC, et al.
Publicado: (2017)

Oligometastatic carcinoma prostate – An overview of the last decade
por: Shah, Milap J, et al.
Publicado: (2023)

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC
por: Antonoff, Mara B., et al.
Publicado: (2022)

Use of statins or NSAIDs and survival of patients with high-grade glioma
por: Seliger, Corinna, et al.
Publicado: (2018)

Interobserver Variability in the Assessment of Tumor Budding in pT 3/4 Colon Cancer: Improvement by Supporting Immunohistochemistry?
por: Martin, Benedikt, et al.
Publicado: (2020)

4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival
por: Inwald, Elisabeth Christine, et al.
Publicado: (2015)

Highlights on the Management of Oligometastatic Disease
por: Alshehri, Salem M., et al.
Publicado: (2020)

Survival and prognostic factors in oligometastatic breast cancer
por: van Ommen-Nijhof, Annemiek, et al.
Publicado: (2022)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Imaging of Oligometastatic Disease
por: Vietti Violi, Naik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hr1vbglti7qfbke171osl5d26q